A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07221162 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

140

Enrollment

NIH

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Aluminum Hydroxide Suspension
BIOLOGICAL: Boost-2867
BIOLOGICAL: CpG 7909
OTHER: Sodium Chloride, 0.9%

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)